
Five-year survival for acute lymphoblastic leukemia among children and adolescents treated through Children's Oncology Group clinical trials increased from 83.7% from 1990 to 1994 to 90.4% from 2000 to 2005, according to a study showing similar gains in 10-year survival. The researchers credited the advances to treatment that comes as part of rigorous clinical trials.

